Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Primary Care Diabetes|October 11, 2023
Improved glycemic control after the use of flash glucose monitoring accompanied by improved treatment satisfaction in patients with non-insulin-treated type 2 diabetes: A post-hoc analysis of a randomized controlled trialAyaka Hayase, Takeshi Onoue, Tomoko Kobayashi, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 25, 2011
[Epstein-Barr virus-associated post-transplant lymphoproliferative disorder diagnosed by the episode of intestinal perforation following allogeneic hematopoietic stem cell transplantation]Mizuki Aimoto, Takahisa Yamane, Atushi Inoue, et al.Plos One|January 29, 2020
Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trialTakeshi Onoue, Motomitsu Goto, Eri Wada, et al.Diabetes|March 10, 2025
Novel cell-to-cell communications between macrophages and fibroblasts regulate obesity-induced adipose tissue fibrosisHiro Kohda, Miyako Tanaka, Shigeyuki Shichino, et al.BMJ Open Diabetes Research & Care|June 11, 2020
Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trialEri Wada, Takeshi Onoue, Tomoko Kobayashi, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 9, 2011
[Membranous nephropathy with nephrotic syndrome developed after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia]Mizuki Aimoto, Takahisa Yamane, Mitsuru Ichii, et al.British Journal of Cancer|February 4, 2020
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective studyNorio Okada, Shintaro Iwama, Takayuki Okuji, et al.Pageof 2